CDKN2C and central nervous system cancer: Survey of a panel of 747 human cancer cell lines of 32 anatomical origins for genomic status of CDKN2A (p16INK4A and p14ARF) and CDKN2C revealed that codeletion of these two loci was observed predominantly in glioma tumor cell lines (Table S3).